Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostatChandra R. Tate(Tulane University), Bridgette M. Collins‐Burow(Tulane University)Breast Cancer ResearchMay 21, 201210.1186/bcr3192Cited by 263SaveCiteExport RISWatch citationsRelated PapersRegulation of triple-negative breast cancer cell metastasis by the tumor-suppressor liver kinase B1|Oncogenesis|2015|35Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor|PLoS ONE|2020|18